Latest news
BioInvent comments on FDA's Fast Track for BI-1808 in ovarian cancer - biostock.sebiostock.se · Mon, 10 Aug 2026 09:16:29 GMTOTLK Stock Rocket Nearly 140%: FDA's Lytenava FDR Approval Pushes Stock On Track For Best Week On Record - StocktwitsStocktwits · Sat, 08 Aug 2026 06:03:50 GMTXenon Pharmaceuticals' Azetukalner NDA Filing Remains on Track After FDA Meeting, RBC Says - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 18:02:12 GMTBioInvent wins FDA Fast Track for BI-1808 after encouraging ovarian cancer data - AllSciAllSci · Fri, 07 Aug 2026 16:28:01 GMTFDA PDUFA Watch: Neurology Decisions to Track Through Late September - NeurologyLiveNeurologyLive · Thu, 06 Aug 2026 14:15:45 GMTHow Hedge Funds Use FOIA to Track FDA’s Regulatory Aftermath - Law Street MediaLaw Street Media · Wed, 05 Aug 2026 19:14:06 GMTFDA Fast Track and Priority Review Designations Granted in July 2026 - Oncology News CentralOncology News Central · Mon, 03 Aug 2026 13:59:35 GMTCema-Cel Receives FDA RMAT, Fast Track Designations in First-Line LBCL - CancerNetworkCancerNetwork · Thu, 30 Jul 2026 15:07:19 GMT